The Journal of Neuroscience, February 4, 2009, 29(5):1257-1266; doi:10.1523/JNEUROSCI.4411-08.2009
Previous Article | Next Article 
Neurobiology of Disease
Neuroprotective Effects of Inositol 1,4,5-Trisphosphate Receptor C-Terminal Fragment in a Huntington's Disease Mouse Model
Tie-Shan Tang,1
Caixia Guo,2
Hongyu Wang,1
Xi Chen,1 and
Ilya Bezprozvanny1
Departments of 1Physiology and 2Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390
Correspondence should be addressed to Dr. Ilya Bezprozvanny at the above address. Email: ilya.bezprozvanny{at}utsouthwestern.edu
Huntington's disease (HD) is a dominantly inherited, progressive neurodegenerative disease caused by an expanded polyglutamine tract in huntingtin protein (Htt). Medium spiny striatal neurons (MSNs) are primarily affected in HD. Mutant huntingtin protein (Httexp) specifically binds to and activates type 1 inositol 1,4,5-trisphosphate receptor (InsP3R1), an intracellular Ca2+ release channel. Httexp–InsP3R1 association is mediated by a cytosolic C-terminal tail of InsP3R1 (a 122-aa-long IC10 fragment). To evaluate an importance of Httexp association with InsP3R1 for HD pathology, we generated lentiviral and adeno-associated viruses expressing GFP-IC10 fusion protein and performed a series of experiments with YAC128 HD transgenic mouse. Infection with Lenti-GFP-IC10 virus stabilized Ca2+ signaling in cultured YAC128 MSNs and protected YAC128 MSNs from glutamate-induced apoptosis. Intrastriatal injections of AAV1-GFP-IC10 significantly alleviated motor deficits and reduced MSN loss and shrinkage in YAC128 mice. Our results demonstrate an importance of InsP3R1–Httexp association for HD pathogenesis and suggested that InsP3R1 is a potential therapeutic target for HD. Our data also support potential use of IC10 peptide as a novel HD therapeutic agent.
Key words: calcium signaling; neurodegeneration; InsP3R; recombinant adeno-associated virus (AAV); Huntington's disease; transgenic mouse; stereology
Received Sept. 15, 2008;
revised Oct. 23, 2008;
accepted Dec. 20, 2008.
Correspondence should be addressed to Dr. Ilya Bezprozvanny at the above address. Email: ilya.bezprozvanny{at}utsouthwestern.edu
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2009 29: i.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
Y. Dai, N. L. Dudek, Q. Li, S. C. Fowler, and N. A. Muma
Striatal Expression of a Calmodulin Fragment Improved Motor Function, Weight Loss, and Neuropathology in the R6/2 Mouse Model of Huntington's Disease
J. Neurosci.,
September 16, 2009;
29(37):
11550 - 11559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu, T.-S. Tang, H. Tu, O. Nelson, E. Herndon, D. P. Huynh, S. M. Pulst, and I. Bezprozvanny
Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2
J. Neurosci.,
July 22, 2009;
29(29):
9148 - 9162.
[Abstract]
[Full Text]
[PDF]
|
 |
|